nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—CYP2C9—brain cancer	0.516	1	CbGaD
Indinavir—ABCC1—Etoposide—brain cancer	0.0577	0.158	CbGbCtD
Indinavir—CYP2D6—Lomustine—brain cancer	0.0543	0.149	CbGbCtD
Indinavir—ABCC2—Carboplatin—brain cancer	0.0509	0.139	CbGbCtD
Indinavir—ABCC2—Etoposide—brain cancer	0.0427	0.117	CbGbCtD
Indinavir—CYP2D6—Hydroxyurea—brain cancer	0.0412	0.113	CbGbCtD
Indinavir—CYP3A4—Temozolomide—brain cancer	0.0406	0.111	CbGbCtD
Indinavir—CYP3A4—Lomustine—brain cancer	0.0345	0.0944	CbGbCtD
Indinavir—CYP3A5—Etoposide—brain cancer	0.0214	0.0585	CbGbCtD
Indinavir—ABCB1—Etoposide—brain cancer	0.0139	0.0381	CbGbCtD
Indinavir—CYP3A4—Etoposide—brain cancer	0.00835	0.0228	CbGbCtD
Indinavir—Lopinavir—CYP2C9—brain cancer	0.00171	0.39	CrCbGaD
Indinavir—Nelfinavir—CYP2C9—brain cancer	0.00159	0.362	CrCbGaD
Indinavir—Saquinavir—CYP2C9—brain cancer	0.00109	0.248	CrCbGaD
Indinavir—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00044	0.049	CbGpPWpGaD
Indinavir—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000401	0.0446	CbGpPWpGaD
Indinavir—Muscular weakness—Temozolomide—brain cancer	0.000381	0.00363	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000381	0.00363	CcSEcCtD
Indinavir—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000378	0.0421	CbGpPWpGaD
Indinavir—Loss of consciousness—Procarbazine—brain cancer	0.000378	0.00361	CcSEcCtD
Indinavir—Abdominal distension—Temozolomide—brain cancer	0.000375	0.00358	CcSEcCtD
Indinavir—Cough—Procarbazine—brain cancer	0.000375	0.00358	CcSEcCtD
Indinavir—Myalgia—Procarbazine—brain cancer	0.000366	0.00349	CcSEcCtD
Indinavir—Arthralgia—Procarbazine—brain cancer	0.000366	0.00349	CcSEcCtD
Indinavir—Anxiety—Procarbazine—brain cancer	0.000365	0.00348	CcSEcCtD
Indinavir—Dry mouth—Procarbazine—brain cancer	0.000358	0.00342	CcSEcCtD
Indinavir—Anaphylactoid reaction—Etoposide—brain cancer	0.000357	0.00341	CcSEcCtD
Indinavir—Vomiting—Lomustine—brain cancer	0.000351	0.00335	CcSEcCtD
Indinavir—Oedema—Procarbazine—brain cancer	0.000351	0.00335	CcSEcCtD
Indinavir—Dysuria—Temozolomide—brain cancer	0.000349	0.00333	CcSEcCtD
Indinavir—Hyperglycaemia—Carmustine—brain cancer	0.000348	0.00332	CcSEcCtD
Indinavir—Upper respiratory tract infection—Temozolomide—brain cancer	0.000347	0.00331	CcSEcCtD
Indinavir—Pneumonia—Carmustine—brain cancer	0.000346	0.0033	CcSEcCtD
Indinavir—Shock—Procarbazine—brain cancer	0.000345	0.00329	CcSEcCtD
Indinavir—Pollakiuria—Temozolomide—brain cancer	0.000344	0.00329	CcSEcCtD
Indinavir—Thrombocytopenia—Procarbazine—brain cancer	0.000343	0.00328	CcSEcCtD
Indinavir—Chills—Hydroxyurea—brain cancer	0.000343	0.00327	CcSEcCtD
Indinavir—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000341	0.038	CbGpPWpGaD
Indinavir—Weight increased—Temozolomide—brain cancer	0.000339	0.00324	CcSEcCtD
Indinavir—Hyperhidrosis—Procarbazine—brain cancer	0.000339	0.00324	CcSEcCtD
Indinavir—Renal failure—Carmustine—brain cancer	0.000338	0.00323	CcSEcCtD
Indinavir—Alopecia—Hydroxyurea—brain cancer	0.000338	0.00322	CcSEcCtD
Indinavir—Neuropathy peripheral—Carmustine—brain cancer	0.000337	0.00322	CcSEcCtD
Indinavir—Hyperglycaemia—Temozolomide—brain cancer	0.000336	0.00321	CcSEcCtD
Indinavir—Urinary tract infection—Carmustine—brain cancer	0.000334	0.00319	CcSEcCtD
Indinavir—Pneumonia—Temozolomide—brain cancer	0.000334	0.00319	CcSEcCtD
Indinavir—Anorexia—Procarbazine—brain cancer	0.000334	0.00319	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00033	0.00315	CcSEcCtD
Indinavir—Nausea—Lomustine—brain cancer	0.000328	0.00313	CcSEcCtD
Indinavir—Neuropathy peripheral—Temozolomide—brain cancer	0.000326	0.00311	CcSEcCtD
Indinavir—Urinary tract infection—Temozolomide—brain cancer	0.000323	0.00309	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00032	0.00305	CcSEcCtD
Indinavir—Insomnia—Procarbazine—brain cancer	0.000317	0.00303	CcSEcCtD
Indinavir—Paraesthesia—Procarbazine—brain cancer	0.000315	0.00301	CcSEcCtD
Indinavir—Hepatobiliary disease—Temozolomide—brain cancer	0.000314	0.003	CcSEcCtD
Indinavir—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000314	0.0349	CbGpPWpGaD
Indinavir—Sinusitis—Temozolomide—brain cancer	0.000312	0.00298	CcSEcCtD
Indinavir—Somnolence—Procarbazine—brain cancer	0.000312	0.00298	CcSEcCtD
Indinavir—Cramp muscle—Etoposide—brain cancer	0.000311	0.00297	CcSEcCtD
Indinavir—Haemoglobin—Carmustine—brain cancer	0.00031	0.00296	CcSEcCtD
Indinavir—Haemorrhage—Carmustine—brain cancer	0.000309	0.00295	CcSEcCtD
Indinavir—Ill-defined disorder—Hydroxyurea—brain cancer	0.000309	0.00295	CcSEcCtD
Indinavir—Anaemia—Hydroxyurea—brain cancer	0.000307	0.00294	CcSEcCtD
Indinavir—Hypoaesthesia—Carmustine—brain cancer	0.000307	0.00293	CcSEcCtD
Indinavir—Decreased appetite—Procarbazine—brain cancer	0.000305	0.00291	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Etoposide—brain cancer	0.000305	0.00291	CcSEcCtD
Indinavir—Connective tissue disorder—Carmustine—brain cancer	0.000304	0.0029	CcSEcCtD
Indinavir—Fatigue—Procarbazine—brain cancer	0.000302	0.00289	CcSEcCtD
Indinavir—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000301	0.0336	CbGpPWpGaD
Indinavir—Haemoglobin—Temozolomide—brain cancer	0.0003	0.00286	CcSEcCtD
Indinavir—Malaise—Hydroxyurea—brain cancer	0.0003	0.00286	CcSEcCtD
Indinavir—Constipation—Procarbazine—brain cancer	0.0003	0.00286	CcSEcCtD
Indinavir—Pain—Procarbazine—brain cancer	0.0003	0.00286	CcSEcCtD
Indinavir—Hepatitis—Temozolomide—brain cancer	0.000298	0.00285	CcSEcCtD
Indinavir—Haemorrhage—Temozolomide—brain cancer	0.000298	0.00285	CcSEcCtD
Indinavir—Hypoaesthesia—Temozolomide—brain cancer	0.000297	0.00284	CcSEcCtD
Indinavir—Pharyngitis—Temozolomide—brain cancer	0.000296	0.00283	CcSEcCtD
Indinavir—Urinary tract disorder—Temozolomide—brain cancer	0.000295	0.00281	CcSEcCtD
Indinavir—Connective tissue disorder—Temozolomide—brain cancer	0.000293	0.0028	CcSEcCtD
Indinavir—Urethral disorder—Temozolomide—brain cancer	0.000293	0.00279	CcSEcCtD
Indinavir—Feeling abnormal—Procarbazine—brain cancer	0.000289	0.00276	CcSEcCtD
Indinavir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000287	0.032	CbGpPWpGaD
Indinavir—Gastrointestinal pain—Procarbazine—brain cancer	0.000287	0.00274	CcSEcCtD
Indinavir—Flushing—Carmustine—brain cancer	0.000287	0.00274	CcSEcCtD
Indinavir—Erythema multiforme—Temozolomide—brain cancer	0.000282	0.00269	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000281	0.00268	CcSEcCtD
Indinavir—Discomfort—Hydroxyurea—brain cancer	0.00028	0.00267	CcSEcCtD
Indinavir—Urticaria—Procarbazine—brain cancer	0.000279	0.00266	CcSEcCtD
Indinavir—Abdominal pain—Procarbazine—brain cancer	0.000277	0.00265	CcSEcCtD
Indinavir—Body temperature increased—Procarbazine—brain cancer	0.000277	0.00265	CcSEcCtD
Indinavir—Flushing—Temozolomide—brain cancer	0.000277	0.00264	CcSEcCtD
Indinavir—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000274	0.0304	CbGpPWpGaD
Indinavir—Alopecia—Carmustine—brain cancer	0.000273	0.00261	CcSEcCtD
Indinavir—Oedema—Hydroxyurea—brain cancer	0.000271	0.00259	CcSEcCtD
Indinavir—Immune system disorder—Temozolomide—brain cancer	0.00027	0.00257	CcSEcCtD
Indinavir—Malnutrition—Carmustine—brain cancer	0.000269	0.00257	CcSEcCtD
Indinavir—Chills—Temozolomide—brain cancer	0.000268	0.00256	CcSEcCtD
Indinavir—Pneumonia—Etoposide—brain cancer	0.000268	0.00255	CcSEcCtD
Indinavir—Nervous system disorder—Hydroxyurea—brain cancer	0.000266	0.00254	CcSEcCtD
Indinavir—Thrombocytopenia—Hydroxyurea—brain cancer	0.000266	0.00254	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000264	0.00252	CcSEcCtD
Indinavir—Alopecia—Temozolomide—brain cancer	0.000264	0.00252	CcSEcCtD
Indinavir—Skin disorder—Hydroxyurea—brain cancer	0.000264	0.00252	CcSEcCtD
Indinavir—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000263	0.0293	CbGpPWpGaD
Indinavir—Acute coronary syndrome—Etoposide—brain cancer	0.000262	0.0025	CcSEcCtD
Indinavir—Renal failure—Etoposide—brain cancer	0.000262	0.0025	CcSEcCtD
Indinavir—Myocardial infarction—Etoposide—brain cancer	0.000261	0.00249	CcSEcCtD
Indinavir—Neuropathy peripheral—Etoposide—brain cancer	0.000261	0.00249	CcSEcCtD
Indinavir—Back pain—Carmustine—brain cancer	0.00026	0.00248	CcSEcCtD
Indinavir—Malnutrition—Temozolomide—brain cancer	0.00026	0.00248	CcSEcCtD
Indinavir—Jaundice—Etoposide—brain cancer	0.000259	0.00248	CcSEcCtD
Indinavir—Anorexia—Hydroxyurea—brain cancer	0.000259	0.00247	CcSEcCtD
Indinavir—Hypersensitivity—Procarbazine—brain cancer	0.000258	0.00247	CcSEcCtD
Indinavir—Dysgeusia—Temozolomide—brain cancer	0.000254	0.00243	CcSEcCtD
Indinavir—Vision blurred—Carmustine—brain cancer	0.000253	0.00242	CcSEcCtD
Indinavir—Tremor—Carmustine—brain cancer	0.000252	0.00241	CcSEcCtD
Indinavir—Asthenia—Procarbazine—brain cancer	0.000252	0.0024	CcSEcCtD
Indinavir—Hepatobiliary disease—Etoposide—brain cancer	0.000252	0.0024	CcSEcCtD
Indinavir—Back pain—Temozolomide—brain cancer	0.000251	0.0024	CcSEcCtD
Indinavir—Anaemia—Carmustine—brain cancer	0.000249	0.00237	CcSEcCtD
Indinavir—Pruritus—Procarbazine—brain cancer	0.000248	0.00237	CcSEcCtD
Indinavir—Agitation—Carmustine—brain cancer	0.000247	0.00236	CcSEcCtD
Indinavir—Vision blurred—Temozolomide—brain cancer	0.000245	0.00234	CcSEcCtD
Indinavir—Tremor—Temozolomide—brain cancer	0.000243	0.00232	CcSEcCtD
Indinavir—Dyspnoea—Hydroxyurea—brain cancer	0.000242	0.00231	CcSEcCtD
Indinavir—Somnolence—Hydroxyurea—brain cancer	0.000241	0.0023	CcSEcCtD
Indinavir—Ill-defined disorder—Temozolomide—brain cancer	0.000241	0.0023	CcSEcCtD
Indinavir—Anaemia—Temozolomide—brain cancer	0.00024	0.00229	CcSEcCtD
Indinavir—Diarrhoea—Procarbazine—brain cancer	0.00024	0.00229	CcSEcCtD
Indinavir—Dyspepsia—Hydroxyurea—brain cancer	0.000239	0.00228	CcSEcCtD
Indinavir—Agitation—Temozolomide—brain cancer	0.000239	0.00228	CcSEcCtD
Indinavir—Hypoaesthesia—Etoposide—brain cancer	0.000238	0.00227	CcSEcCtD
Indinavir—Angioedema—Temozolomide—brain cancer	0.000237	0.00227	CcSEcCtD
Indinavir—Decreased appetite—Hydroxyurea—brain cancer	0.000236	0.00225	CcSEcCtD
Indinavir—Urinary tract disorder—Etoposide—brain cancer	0.000236	0.00225	CcSEcCtD
Indinavir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000234	0.00224	CcSEcCtD
Indinavir—Malaise—Temozolomide—brain cancer	0.000234	0.00224	CcSEcCtD
Indinavir—Urethral disorder—Etoposide—brain cancer	0.000234	0.00224	CcSEcCtD
Indinavir—Fatigue—Hydroxyurea—brain cancer	0.000234	0.00223	CcSEcCtD
Indinavir—Vertigo—Temozolomide—brain cancer	0.000233	0.00223	CcSEcCtD
Indinavir—Pain—Hydroxyurea—brain cancer	0.000232	0.00222	CcSEcCtD
Indinavir—Constipation—Hydroxyurea—brain cancer	0.000232	0.00222	CcSEcCtD
Indinavir—Dizziness—Procarbazine—brain cancer	0.000232	0.00221	CcSEcCtD
Indinavir—Palpitations—Temozolomide—brain cancer	0.00023	0.00219	CcSEcCtD
Indinavir—Myalgia—Carmustine—brain cancer	0.000229	0.00219	CcSEcCtD
Indinavir—Chest pain—Carmustine—brain cancer	0.000229	0.00219	CcSEcCtD
Indinavir—Anxiety—Carmustine—brain cancer	0.000228	0.00218	CcSEcCtD
Indinavir—Cough—Temozolomide—brain cancer	0.000227	0.00216	CcSEcCtD
Indinavir—Erythema multiforme—Etoposide—brain cancer	0.000226	0.00216	CcSEcCtD
Indinavir—Feeling abnormal—Hydroxyurea—brain cancer	0.000224	0.00214	CcSEcCtD
Indinavir—Vomiting—Procarbazine—brain cancer	0.000223	0.00213	CcSEcCtD
Indinavir—Flushing—Etoposide—brain cancer	0.000222	0.00212	CcSEcCtD
Indinavir—Arthralgia—Temozolomide—brain cancer	0.000221	0.00211	CcSEcCtD
Indinavir—Myalgia—Temozolomide—brain cancer	0.000221	0.00211	CcSEcCtD
Indinavir—Rash—Procarbazine—brain cancer	0.000221	0.00211	CcSEcCtD
Indinavir—Dermatitis—Procarbazine—brain cancer	0.000221	0.00211	CcSEcCtD
Indinavir—Anxiety—Temozolomide—brain cancer	0.00022	0.0021	CcSEcCtD
Indinavir—Headache—Procarbazine—brain cancer	0.00022	0.0021	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00022	0.0021	CcSEcCtD
Indinavir—Oedema—Carmustine—brain cancer	0.000219	0.0021	CcSEcCtD
Indinavir—Discomfort—Temozolomide—brain cancer	0.000219	0.00209	CcSEcCtD
Indinavir—Dry mouth—Temozolomide—brain cancer	0.000216	0.00207	CcSEcCtD
Indinavir—Immune system disorder—Etoposide—brain cancer	0.000216	0.00206	CcSEcCtD
Indinavir—Thrombocytopenia—Carmustine—brain cancer	0.000215	0.00205	CcSEcCtD
Indinavir—Body temperature increased—Hydroxyurea—brain cancer	0.000215	0.00205	CcSEcCtD
Indinavir—Chills—Etoposide—brain cancer	0.000214	0.00205	CcSEcCtD
Indinavir—Oedema—Temozolomide—brain cancer	0.000212	0.00202	CcSEcCtD
Indinavir—Anaphylactic shock—Temozolomide—brain cancer	0.000212	0.00202	CcSEcCtD
Indinavir—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000211	0.0235	CbGpPWpGaD
Indinavir—Alopecia—Etoposide—brain cancer	0.000211	0.00202	CcSEcCtD
Indinavir—Anorexia—Carmustine—brain cancer	0.000209	0.002	CcSEcCtD
Indinavir—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000208	0.0232	CbGpPWpGaD
Indinavir—Nausea—Procarbazine—brain cancer	0.000208	0.00199	CcSEcCtD
Indinavir—Nervous system disorder—Temozolomide—brain cancer	0.000208	0.00199	CcSEcCtD
Indinavir—Thrombocytopenia—Temozolomide—brain cancer	0.000208	0.00198	CcSEcCtD
Indinavir—Skin disorder—Temozolomide—brain cancer	0.000206	0.00197	CcSEcCtD
Indinavir—Hyperhidrosis—Temozolomide—brain cancer	0.000205	0.00196	CcSEcCtD
Indinavir—Dysgeusia—Etoposide—brain cancer	0.000204	0.00194	CcSEcCtD
Indinavir—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000203	0.0226	CbGpPWpGaD
Indinavir—Anorexia—Temozolomide—brain cancer	0.000202	0.00193	CcSEcCtD
Indinavir—Back pain—Etoposide—brain cancer	0.000201	0.00192	CcSEcCtD
Indinavir—Hypersensitivity—Hydroxyurea—brain cancer	0.0002	0.00191	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Carmustine—brain cancer	0.0002	0.00191	CcSEcCtD
Indinavir—Muscle spasms—Etoposide—brain cancer	0.0002	0.00191	CcSEcCtD
Indinavir—Insomnia—Carmustine—brain cancer	0.000198	0.00189	CcSEcCtD
Indinavir—Paraesthesia—Carmustine—brain cancer	0.000197	0.00188	CcSEcCtD
Indinavir—Dyspnoea—Carmustine—brain cancer	0.000196	0.00187	CcSEcCtD
Indinavir—Somnolence—Carmustine—brain cancer	0.000195	0.00186	CcSEcCtD
Indinavir—Asthenia—Hydroxyurea—brain cancer	0.000195	0.00186	CcSEcCtD
Indinavir—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000195	0.0217	CbGpPWpGaD
Indinavir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000193	0.00184	CcSEcCtD
Indinavir—Ill-defined disorder—Etoposide—brain cancer	0.000193	0.00184	CcSEcCtD
Indinavir—Anaemia—Etoposide—brain cancer	0.000192	0.00183	CcSEcCtD
Indinavir—Insomnia—Temozolomide—brain cancer	0.000192	0.00183	CcSEcCtD
Indinavir—Decreased appetite—Carmustine—brain cancer	0.000191	0.00182	CcSEcCtD
Indinavir—Paraesthesia—Temozolomide—brain cancer	0.00019	0.00182	CcSEcCtD
Indinavir—Gastrointestinal disorder—Carmustine—brain cancer	0.000189	0.00181	CcSEcCtD
Indinavir—Dyspnoea—Temozolomide—brain cancer	0.000189	0.00181	CcSEcCtD
Indinavir—Somnolence—Temozolomide—brain cancer	0.000189	0.0018	CcSEcCtD
Indinavir—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000188	0.0209	CbGpPWpGaD
Indinavir—Pain—Carmustine—brain cancer	0.000188	0.00179	CcSEcCtD
Indinavir—Constipation—Carmustine—brain cancer	0.000188	0.00179	CcSEcCtD
Indinavir—Malaise—Etoposide—brain cancer	0.000187	0.00179	CcSEcCtD
Indinavir—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000187	0.0208	CbGpPWpGaD
Indinavir—Vertigo—Etoposide—brain cancer	0.000187	0.00178	CcSEcCtD
Indinavir—Dyspepsia—Temozolomide—brain cancer	0.000187	0.00178	CcSEcCtD
Indinavir—Diarrhoea—Hydroxyurea—brain cancer	0.000186	0.00177	CcSEcCtD
Indinavir—Decreased appetite—Temozolomide—brain cancer	0.000184	0.00176	CcSEcCtD
Indinavir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000183	0.00175	CcSEcCtD
Indinavir—Fatigue—Temozolomide—brain cancer	0.000183	0.00175	CcSEcCtD
Indinavir—Loss of consciousness—Etoposide—brain cancer	0.000183	0.00174	CcSEcCtD
Indinavir—Cough—Etoposide—brain cancer	0.000181	0.00173	CcSEcCtD
Indinavir—Pain—Temozolomide—brain cancer	0.000181	0.00173	CcSEcCtD
Indinavir—Constipation—Temozolomide—brain cancer	0.000181	0.00173	CcSEcCtD
Indinavir—Feeling abnormal—Carmustine—brain cancer	0.000181	0.00173	CcSEcCtD
Indinavir—Dizziness—Hydroxyurea—brain cancer	0.00018	0.00171	CcSEcCtD
Indinavir—Gastrointestinal pain—Carmustine—brain cancer	0.000179	0.00171	CcSEcCtD
Indinavir—Chest pain—Etoposide—brain cancer	0.000177	0.00169	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000176	0.00168	CcSEcCtD
Indinavir—Discomfort—Etoposide—brain cancer	0.000175	0.00167	CcSEcCtD
Indinavir—Feeling abnormal—Temozolomide—brain cancer	0.000175	0.00167	CcSEcCtD
Indinavir—Body temperature increased—Carmustine—brain cancer	0.000173	0.00166	CcSEcCtD
Indinavir—Abdominal pain—Carmustine—brain cancer	0.000173	0.00166	CcSEcCtD
Indinavir—Gastrointestinal pain—Temozolomide—brain cancer	0.000173	0.00166	CcSEcCtD
Indinavir—Vomiting—Hydroxyurea—brain cancer	0.000173	0.00165	CcSEcCtD
Indinavir—Rash—Hydroxyurea—brain cancer	0.000171	0.00163	CcSEcCtD
Indinavir—Dermatitis—Hydroxyurea—brain cancer	0.000171	0.00163	CcSEcCtD
Indinavir—Headache—Hydroxyurea—brain cancer	0.00017	0.00162	CcSEcCtD
Indinavir—Anaphylactic shock—Etoposide—brain cancer	0.00017	0.00162	CcSEcCtD
Indinavir—Urticaria—Temozolomide—brain cancer	0.000168	0.00161	CcSEcCtD
Indinavir—Body temperature increased—Temozolomide—brain cancer	0.000168	0.0016	CcSEcCtD
Indinavir—Abdominal pain—Temozolomide—brain cancer	0.000168	0.0016	CcSEcCtD
Indinavir—Thrombocytopenia—Etoposide—brain cancer	0.000166	0.00159	CcSEcCtD
Indinavir—Skin disorder—Etoposide—brain cancer	0.000165	0.00157	CcSEcCtD
Indinavir—Hyperhidrosis—Etoposide—brain cancer	0.000164	0.00157	CcSEcCtD
Indinavir—Anorexia—Etoposide—brain cancer	0.000162	0.00154	CcSEcCtD
Indinavir—Hypersensitivity—Carmustine—brain cancer	0.000162	0.00154	CcSEcCtD
Indinavir—Nausea—Hydroxyurea—brain cancer	0.000161	0.00154	CcSEcCtD
Indinavir—Asthenia—Carmustine—brain cancer	0.000157	0.0015	CcSEcCtD
Indinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000157	0.0175	CbGpPWpGaD
Indinavir—Hypersensitivity—Temozolomide—brain cancer	0.000156	0.00149	CcSEcCtD
Indinavir—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000155	0.0173	CbGpPWpGaD
Indinavir—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000155	0.0172	CbGpPWpGaD
Indinavir—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000153	0.017	CbGpPWpGaD
Indinavir—Paraesthesia—Etoposide—brain cancer	0.000152	0.00145	CcSEcCtD
Indinavir—Asthenia—Temozolomide—brain cancer	0.000152	0.00145	CcSEcCtD
Indinavir—Dyspnoea—Etoposide—brain cancer	0.000151	0.00144	CcSEcCtD
Indinavir—Somnolence—Etoposide—brain cancer	0.000151	0.00144	CcSEcCtD
Indinavir—Diarrhoea—Carmustine—brain cancer	0.00015	0.00143	CcSEcCtD
Indinavir—Pruritus—Temozolomide—brain cancer	0.00015	0.00143	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—brain cancer	0.000148	0.00141	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—brain cancer	0.000146	0.0014	CcSEcCtD
Indinavir—Fatigue—Etoposide—brain cancer	0.000146	0.0014	CcSEcCtD
Indinavir—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000145	0.0162	CbGpPWpGaD
Indinavir—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000145	0.0162	CbGpPWpGaD
Indinavir—Dizziness—Carmustine—brain cancer	0.000145	0.00139	CcSEcCtD
Indinavir—Pain—Etoposide—brain cancer	0.000145	0.00139	CcSEcCtD
Indinavir—Constipation—Etoposide—brain cancer	0.000145	0.00139	CcSEcCtD
Indinavir—Diarrhoea—Temozolomide—brain cancer	0.000145	0.00139	CcSEcCtD
Indinavir—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000142	0.0158	CbGpPWpGaD
Indinavir—Dizziness—Temozolomide—brain cancer	0.00014	0.00134	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—brain cancer	0.00014	0.00134	CcSEcCtD
Indinavir—Vomiting—Carmustine—brain cancer	0.00014	0.00133	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—brain cancer	0.000139	0.00132	CcSEcCtD
Indinavir—Rash—Carmustine—brain cancer	0.000138	0.00132	CcSEcCtD
Indinavir—Dermatitis—Carmustine—brain cancer	0.000138	0.00132	CcSEcCtD
Indinavir—Headache—Carmustine—brain cancer	0.000137	0.00131	CcSEcCtD
Indinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000135	0.015	CbGpPWpGaD
Indinavir—Vomiting—Temozolomide—brain cancer	0.000135	0.00129	CcSEcCtD
Indinavir—Urticaria—Etoposide—brain cancer	0.000135	0.00129	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—brain cancer	0.000134	0.00128	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—brain cancer	0.000134	0.00128	CcSEcCtD
Indinavir—Rash—Temozolomide—brain cancer	0.000134	0.00128	CcSEcCtD
Indinavir—Dermatitis—Temozolomide—brain cancer	0.000134	0.00128	CcSEcCtD
Indinavir—Headache—Temozolomide—brain cancer	0.000133	0.00127	CcSEcCtD
Indinavir—Nausea—Carmustine—brain cancer	0.00013	0.00124	CcSEcCtD
Indinavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000127	0.0142	CbGpPWpGaD
Indinavir—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000127	0.0142	CbGpPWpGaD
Indinavir—Nausea—Temozolomide—brain cancer	0.000126	0.0012	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—brain cancer	0.000125	0.00119	CcSEcCtD
Indinavir—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000122	0.0136	CbGpPWpGaD
Indinavir—Asthenia—Etoposide—brain cancer	0.000122	0.00116	CcSEcCtD
Indinavir—Pruritus—Etoposide—brain cancer	0.00012	0.00115	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—brain cancer	0.000116	0.00111	CcSEcCtD
Indinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000114	0.0126	CbGpPWpGaD
Indinavir—Dizziness—Etoposide—brain cancer	0.000112	0.00107	CcSEcCtD
Indinavir—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000112	0.0125	CbGpPWpGaD
Indinavir—Vomiting—Etoposide—brain cancer	0.000108	0.00103	CcSEcCtD
Indinavir—Rash—Etoposide—brain cancer	0.000107	0.00102	CcSEcCtD
Indinavir—Dermatitis—Etoposide—brain cancer	0.000107	0.00102	CcSEcCtD
Indinavir—Headache—Etoposide—brain cancer	0.000106	0.00101	CcSEcCtD
Indinavir—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000102	0.0113	CbGpPWpGaD
Indinavir—Nausea—Etoposide—brain cancer	0.000101	0.000962	CcSEcCtD
Indinavir—CYP3A5—Irinotecan Pathway—APC—brain cancer	9.65e-05	0.0107	CbGpPWpGaD
Indinavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.21e-05	0.0103	CbGpPWpGaD
Indinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.78e-05	0.00978	CbGpPWpGaD
Indinavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	8.73e-05	0.00972	CbGpPWpGaD
Indinavir—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.67e-05	0.00965	CbGpPWpGaD
Indinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	8.32e-05	0.00926	CbGpPWpGaD
Indinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.08e-05	0.00899	CbGpPWpGaD
Indinavir—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	7.97e-05	0.00887	CbGpPWpGaD
Indinavir—ABCC1—S1P1 pathway—VEGFA—brain cancer	7.17e-05	0.00798	CbGpPWpGaD
Indinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	7.12e-05	0.00792	CbGpPWpGaD
Indinavir—CYP3A7—Biological oxidations—CYP2C9—brain cancer	6.77e-05	0.00753	CbGpPWpGaD
Indinavir—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	6.67e-05	0.00743	CbGpPWpGaD
Indinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.55e-05	0.00729	CbGpPWpGaD
Indinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	5.52e-05	0.00615	CbGpPWpGaD
Indinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	5.28e-05	0.00588	CbGpPWpGaD
Indinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	5.21e-05	0.0058	CbGpPWpGaD
Indinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	4.92e-05	0.00548	CbGpPWpGaD
Indinavir—CYP3A5—Biological oxidations—CYP2C9—brain cancer	4.89e-05	0.00544	CbGpPWpGaD
Indinavir—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	4.82e-05	0.00537	CbGpPWpGaD
Indinavir—CYP3A4—Irinotecan Pathway—APC—brain cancer	4.49e-05	0.00499	CbGpPWpGaD
Indinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	4.28e-05	0.00477	CbGpPWpGaD
Indinavir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	3.98e-05	0.00443	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	3.8e-05	0.00423	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—CYP2C9—brain cancer	3.78e-05	0.00421	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	3.73e-05	0.00415	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—CYP2C9—brain cancer	3.48e-05	0.00387	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	3.46e-05	0.00385	CbGpPWpGaD
Indinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	3.45e-05	0.00384	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	3.43e-05	0.00382	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	3.42e-05	0.00381	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.31e-05	0.00369	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	3.25e-05	0.00362	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.98e-05	0.00332	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.83e-05	0.00315	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	2.77e-05	0.00309	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.42e-05	0.00269	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—PDGFRA—brain cancer	2.35e-05	0.00262	CbGpPWpGaD
Indinavir—ABCC1—Disease—DTX2—brain cancer	2.35e-05	0.00261	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP2C9—brain cancer	2.27e-05	0.00253	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	2.24e-05	0.0025	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.18e-05	0.00242	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.07e-05	0.0023	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	1.96e-05	0.00218	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	1.86e-05	0.00207	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.75e-05	0.00195	CbGpPWpGaD
Indinavir—ABCC1—Disease—HES5—brain cancer	1.72e-05	0.00192	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.63e-05	0.00181	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.6e-05	0.00178	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.58e-05	0.00176	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.57e-05	0.00175	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.5e-05	0.00167	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP2C9—brain cancer	1.47e-05	0.00164	CbGpPWpGaD
Indinavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.47e-05	0.00164	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.45e-05	0.00162	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP2C9—brain cancer	1.33e-05	0.00148	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.29e-05	0.00143	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—IL2—brain cancer	1.28e-05	0.00143	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.28e-05	0.00143	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.26e-05	0.00141	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP2C9—brain cancer	1.26e-05	0.0014	CbGpPWpGaD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.26e-05	0.0014	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—BSG—brain cancer	1.25e-05	0.0014	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.25e-05	0.00139	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.16e-05	0.00129	CbGpPWpGaD
Indinavir—ABCC1—Disease—IDH1—brain cancer	1.16e-05	0.00129	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP2C9—brain cancer	1.16e-05	0.00129	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—BSG—brain cancer	1.13e-05	0.00126	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.11e-05	0.00123	CbGpPWpGaD
Indinavir—ABCC1—Disease—HEY1—brain cancer	1.1e-05	0.00122	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.09e-05	0.00121	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—IDH1—brain cancer	1.08e-05	0.0012	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP2C9—brain cancer	1.08e-05	0.0012	CbGpPWpGaD
Indinavir—ABCC1—Disease—DLL1—brain cancer	1.08e-05	0.0012	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—BSG—brain cancer	1.07e-05	0.00119	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.06e-05	0.00118	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—BSG—brain cancer	9.84e-06	0.0011	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—IDH1—brain cancer	9.7e-06	0.00108	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.68e-06	0.00108	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.56e-06	0.00106	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—IDH1—brain cancer	9.22e-06	0.00103	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—BSG—brain cancer	9.16e-06	0.00102	CbGpPWpGaD
Indinavir—ABCC1—Disease—ENO2—brain cancer	9.16e-06	0.00102	CbGpPWpGaD
Indinavir—ABCC1—Disease—SHH—brain cancer	9.16e-06	0.00102	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9e-06	0.001	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.78e-06	0.000977	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ENO2—brain cancer	8.52e-06	0.000949	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—IDH1—brain cancer	8.46e-06	0.000942	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP2C9—brain cancer	8.36e-06	0.000931	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.9e-06	0.000879	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—IDH1—brain cancer	7.87e-06	0.000877	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ENO2—brain cancer	7.67e-06	0.000854	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.51e-06	0.000836	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.51e-06	0.000836	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ENO2—brain cancer	7.29e-06	0.000811	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—BSG—brain cancer	7.11e-06	0.000792	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.99e-06	0.000778	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ENO2—brain cancer	6.69e-06	0.000745	CbGpPWpGaD
Indinavir—ABCC1—Disease—VAV1—brain cancer	6.62e-06	0.000736	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2C9—brain cancer	6.47e-06	0.00072	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2C9—brain cancer	6.31e-06	0.000703	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ENO2—brain cancer	6.22e-06	0.000693	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.17e-06	0.000687	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—IDH1—brain cancer	6.12e-06	0.000681	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.11e-06	0.000681	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2C9—brain cancer	5.95e-06	0.000662	CbGpPWpGaD
Indinavir—ABCC1—Disease—HES1—brain cancer	5.69e-06	0.000633	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—BSG—brain cancer	5.5e-06	0.000612	CbGpPWpGaD
Indinavir—ABCC1—Disease—PDGFRA—brain cancer	5.42e-06	0.000603	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.38e-06	0.000599	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—BSG—brain cancer	5.37e-06	0.000597	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—BSG—brain cancer	5.06e-06	0.000563	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—BSG—brain cancer	5.01e-06	0.000558	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.95e-06	0.000551	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.84e-06	0.000539	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ENO2—brain cancer	4.83e-06	0.000538	CbGpPWpGaD
Indinavir—ABCC1—Disease—IRS2—brain cancer	4.76e-06	0.000529	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—IDH1—brain cancer	4.73e-06	0.000526	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—IDH1—brain cancer	4.62e-06	0.000514	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—IDH1—brain cancer	4.35e-06	0.000484	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—IDH1—brain cancer	4.31e-06	0.00048	CbGpPWpGaD
Indinavir—ABCC1—Disease—APC—brain cancer	4.2e-06	0.000468	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.07e-06	0.000453	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CG—brain cancer	3.91e-06	0.000435	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2C9—brain cancer	3.89e-06	0.000433	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.85e-06	0.000429	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ENO2—brain cancer	3.74e-06	0.000416	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ENO2—brain cancer	3.65e-06	0.000406	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—brain cancer	3.52e-06	0.000392	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.51e-06	0.000391	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ENO2—brain cancer	3.44e-06	0.000383	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ENO2—brain cancer	3.41e-06	0.000379	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—brain cancer	3.34e-06	0.000372	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BSG—brain cancer	3.31e-06	0.000368	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—brain cancer	3.26e-06	0.000363	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—brain cancer	3.07e-06	0.000342	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—brain cancer	2.86e-06	0.000318	CbGpPWpGaD
Indinavir—ABCC1—Disease—CTNNB1—brain cancer	2.85e-06	0.000318	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—IDH1—brain cancer	2.84e-06	0.000317	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—brain cancer	2.49e-06	0.000277	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—brain cancer	2.31e-06	0.000257	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—brain cancer	2.26e-06	0.000252	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ENO2—brain cancer	2.25e-06	0.00025	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—brain cancer	2.22e-06	0.000247	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—brain cancer	1.71e-06	0.000191	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—brain cancer	1.67e-06	0.000186	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—brain cancer	1.58e-06	0.000176	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—brain cancer	1.56e-06	0.000174	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—brain cancer	1.03e-06	0.000115	CbGpPWpGaD
